C50.112
Malignant neoplasm of central portion of left female breast
Clinical Classification Guidelines
Medical Intelligence & Overview
The ICD-10 code C50.112 refers to a malignant tumor located in the central portion of the left female breast. This type of breast cancer originates from abnormal, uncontrolled cell growth within breast tissue, which has the potential to invade surrounding tissues and spread to other parts of the body. The term 'malignant' highlights the cancerous nature of the tumor, distinguishing it from benign (non-cancerous) growths. This diagnosis relates specifically to tumors situated in the central region of the left breast, an area that can include the nipple, areola, and the tissue directly beneath them.
Causes & Symptoms
Clinical Causes: Genetic mutations and inherited gene mutations such as BRCA1 and BRCA2 Hormonal factors involving prolonged exposure to estrogen and progesterone Environmental exposures, including radiation and certain chemicals Lifestyle factors like smoking, excessive alcohol consumption, and obesity Age and personal or family history of breast cancer Previous breast cancer or benign breast diseases
Key Symptoms: A new lump or mass in the central part of the left breast Persistent pain or tenderness in the affected area Changes in the skin of the breast, such as redness or dimpling Alterations in the nipple, including inversion, discharge, or erosion Unexplained swelling or thickening in the breast Visible changes in the shape or size of the breast
Diagnostic & Treatment
Diagnosis Path: Diagnosing a malignant neoplasm in the breast involves several steps, including:
Treatment Protocols: Treatment strategies for malignant neoplasm of the central left female breast are individualized, depending on tumor size, stage, hormone receptor status, and overall health. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is C50.112 a billable ICD-10 code?
Yes, C50.112 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C50.112?
Clinical documentation must specify the nature of Malignant neoplasm of central portion of left female breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
